ClinicalTrials.gov
public full text
Public Domain
Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia
To demonstrate that scar-based ventricular tachycardia (VT) ablation using the FlexAbility™ ablation catheter system results in a superior clinical outcome compared to routine drug therapy in subjects with documented Monomorphic Ventricular Tachycardia \[MMVT\] (both ischemic and non-ischemic) while maintaining an acceptable safety profile.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study#1228984
- SERF VT Ablation Early Feasibility Study (EFS)#1058160
- IntellaTip MiFi XP Ablation Catheter Trial#1195772
- A Multi-centre Clinical Investigation to Assess the Performance of GentleCath™ Glide Intermittent Catheters#845071
- Full Length Versus Proximal Renal Arteries Ablation#1102029
Record · ID 1451850
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive